Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Amling

Showing results (101-110 of 199) with videos related to

Pageof 20
Sort By:
Urologic Oncology|May 23, 2015
Agent Orange and long-term outcomes after radical prostatectomyAaron E Ovadia, Martha K Terris, William J Aronson, et al.
European Urology|September 18, 2007
PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH databaseStephen J Freedland, James M Hotaling, Nicholas J Fitzsimons, et al.
BJU International|June 16, 2009
Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital databaseDaniel M Moreira, Lionel L Bañez, Joseph C Presti, et al.
BJU International|August 28, 2009
Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH databaseJessica C Lloyd, Lionel L Bañez, William J Aronson, et al.
The Journal of Urology|November 5, 2013
Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxisAmanda A VanDlac, Nick G Cowan, Yiyi Chen, et al.
Cancer|June 28, 2017
Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH databaseStephen J Freedland, Adriana C Vidal, Lauren E Howard, et al.
The Canadian Journal of Urology|July 8, 2026
Evolution toward early stent removal and reduced antibiotic prophylaxis post-cystectomyJessica L Wenzel, Wesley H Chou, Eric J Robinson, et al.
Cancer Medicine|April 9, 2023
A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohortPaige K Kuhlmann, Taofik Oyekunle, Zachary Klaassen, et al.
Journal of the American Geriatrics Society|March 7, 2017
Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation TherapyKerri M Winters-Stone, Esther Moe, Julie N Graff, et al.
BJUI Compass|October 21, 2022
Selecting patients for magnetic resonance imaging cognitive versus ultrasound fusion biopsy of the prostate: A within-patient comparisonMitch Hayes, Solange Bassale, Nicholas H Chakiryan, et al.
Pageof 20

Showing results (101-110 of 199) with videos related to

Sort By:
Pageof 20
Urologic Oncology|May 23, 2015
Agent Orange and long-term outcomes after radical prostatectomyAaron E Ovadia, Martha K Terris, William J Aronson, et al.
European Urology|September 18, 2007
PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH databaseStephen J Freedland, James M Hotaling, Nicholas J Fitzsimons, et al.
BJU International|June 16, 2009
Predictors of secondary treatment following biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital databaseDaniel M Moreira, Lionel L Bañez, Joseph C Presti, et al.
BJU International|August 28, 2009
Estimated blood loss as a predictor of PSA recurrence after radical prostatectomy: results from the SEARCH databaseJessica C Lloyd, Lionel L Bañez, William J Aronson, et al.
The Journal of Urology|November 5, 2013
Timing, incidence and risk factors for venous thromboembolism in patients undergoing radical cystectomy for malignancy: a case for extended duration pharmacological prophylaxisAmanda A VanDlac, Nick G Cowan, Yiyi Chen, et al.
Cancer|June 28, 2017
Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH databaseStephen J Freedland, Adriana C Vidal, Lauren E Howard, et al.
The Canadian Journal of Urology|July 8, 2026
Evolution toward early stent removal and reduced antibiotic prophylaxis post-cystectomyJessica L Wenzel, Wesley H Chou, Eric J Robinson, et al.
Cancer Medicine|April 9, 2023
A modeling study to estimate prostate cancer-specific mortality on active surveillance for men with favorable intermediate-risk prostate cancer: Results from the SEARCH cohortPaige K Kuhlmann, Taofik Oyekunle, Zachary Klaassen, et al.
Journal of the American Geriatrics Society|March 7, 2017
Falls and Frailty in Prostate Cancer Survivors: Current, Past, and Never Users of Androgen Deprivation TherapyKerri M Winters-Stone, Esther Moe, Julie N Graff, et al.
BJUI Compass|October 21, 2022
Selecting patients for magnetic resonance imaging cognitive versus ultrasound fusion biopsy of the prostate: A within-patient comparisonMitch Hayes, Solange Bassale, Nicholas H Chakiryan, et al.
Pageof 20